RxDoctor Payments Data

Bryan Randolph

Podiatrist · Shreveport, LANPI 1649276007

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,181 of the $4,976 with a category attached, or 84.0%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations.

$4,976in general payments, 2019–2025

Across 215 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Mimedx Group, Inc.$865
  • AbbVie$843
  • Melinta Therapeutics, LLC$566
  • Paratek Pharmaceuticals, Inc.$402
  • Organogenesis Inc.$235
  • plus $873 from 19 others

What the payments were for

  • Travel & lodging$79516%
  • Food & beverage$4,18184%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,976 in reported general payments places this provider in the 70th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$150,100
Medicare patients
624
Services billed
2,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl67$1,397
Gabapentin97$1,324
Ciclopirox52$1,272
Mupirocin139$1,192
Doxycycline Hyclate131$1,043
Pregabalin36$831
Ketoconazole31$713
Colchicine11$529
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$506
Febuxostat12$371
Allopurinol30$200
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$189
Ciprofloxacin Hcl13$153
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$145
Methylprednisolone16$106

Paid to pharmacies, not to this prescriber.

Other podiatrist in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →